FindTrial
Sign In

Effect of Turmeric supplementation on type 2 Diabetic patients and subjects with impaired fasting glucose.

Effect of Turmeric as an adjuvant on insulin sensitivity, inflammatory markers, oxidative stress in type 2 Diabetic patients and subjects with impaired fasting glucose

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/02/002442
Enrollment
60
Registered
2012-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetic Patients

Interventions

Intervention1: 1. Metformin ( 500 mg )- drug with Turmeric (Curcuma longa )- intervention : Turmeric two capsules in the morning and two capsules in the night will be administered after four hours of

Sponsors

JIPMER Intramural fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The diabetic patients those who were under metformin treatment (500mg twice a day) minimum for two years were included in the study.

Exclusion criteria

Exclusion criteria: Patients with diabetic complications include retinopathy, nephropathy, neuropathy, hypertension, and other diseases Patients on insulin treatment and hypoglycemic treatment were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Turmeric supplementation reduces insulin resistance by combating oxidative stress and inflammationTimepoint: Four weeks (one month)—

Secondary

MeasureTime frame
Turmeric reduces lipid profile thereby reduces the risk of developing cardiovascular riskTimepoint: Four weeks (one month)—

Countries

India

Contacts

Public ContactDr M G Sridhar

JIPMER

mksbiochem@gmail.com07639846768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026